- Report
- May 2023
- 147 Pages
Global
From €4504EUR$4,949USD£3,826GBP
- Report
- April 2022
- 212 Pages
Global
From €3277EUR$3,600USD£2,783GBP
- Report
- April 2022
- 85 Pages
North America
From €1365EUR$1,500USD£1,160GBP
- Report
- April 2022
- 95 Pages
Middle East, Africa
From €1365EUR$1,500USD£1,160GBP
- Report
- April 2022
- 95 Pages
Asia Pacific
From €1365EUR$1,500USD£1,160GBP
- Report
- July 2023
- 95 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- October 2023
- 146 Pages
Global
From €3211EUR$3,528USD£2,727GBP
€3777EUR$4,150USD£3,208GBP
- Report
- January 2025
- 132 Pages
Global
From €865EUR$950USD£734GBP
- Report
- November 2021
- 545 Pages
Global
From €3641EUR$4,000USD£3,092GBP
- Report
- November 2021
- 1184 Pages
Global
From €5461EUR$6,000USD£4,638GBP
- Report
- November 2021
- 1165 Pages
Global
From €5461EUR$6,000USD£4,638GBP
- Report
- March 2022
- 286 Pages
Global
From €2202EUR$2,419USD£1,870GBP
€3146EUR$3,456USD£2,672GBP
- Book
- March 2023
- 1056 Pages
- Book
- November 2019
- 440 Pages
- Book
- January 2019
- 504 Pages
DNA Methylation is a process in which a methyl group is added to a DNA molecule, resulting in the alteration of gene expression. It is a key epigenetic mechanism that plays a role in the regulation of gene expression and is involved in a variety of biological processes, including development, differentiation, and disease. In the context of genomics, DNA methylation is used to study the regulation of gene expression, identify disease-associated genetic variants, and develop new treatments.
DNA methylation is a rapidly growing field, with a range of applications in the life sciences, including cancer research, drug discovery, and diagnostics. Companies in the DNA methylation market include Illumina, Thermo Fisher Scientific, Agilent Technologies, Merck KGaA, and QIAGEN. Show Less Read more
